162 related articles for article (PubMed ID: 36943242)
21. Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites.
Stewart CJR; Crum CP; McCluggage WG; Park KJ; Rutgers JK; Oliva E; Malpica A; Parkash V; Matias-Guiu X; Ronnett BM
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S75-S92. PubMed ID: 30550485
[TBL] [Abstract][Full Text] [Related]
22. p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes.
Garg K; Leitao MM; Wynveen CA; Sica GL; Shia J; Shi W; Soslow RA
Mod Pathol; 2010 Jan; 23(1):80-92. PubMed ID: 19855378
[TBL] [Abstract][Full Text] [Related]
23. High-grade endometrial carcinomas: Morphologic spectrum and molecular classification.
Zhang C; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):176-186. PubMed ID: 34852949
[TBL] [Abstract][Full Text] [Related]
24. The endometrium.
Silverberg SG
Arch Pathol Lab Med; 2007 Mar; 131(3):372-82. PubMed ID: 17516740
[TBL] [Abstract][Full Text] [Related]
25. Endometrial carcinomas with ambiguous features.
Soslow RA
Semin Diagn Pathol; 2010 Nov; 27(4):261-73. PubMed ID: 21309260
[TBL] [Abstract][Full Text] [Related]
26. Survey Results on Pathologic Aspects of Endocervical Adenocarcinoma by the International Society of Gynecological Pathologists.
McCluggage WG; Rabban JT; Singh N; Oliva E
Int J Gynecol Pathol; 2021 Mar; 40 Suppl 1(Iss 2 Suppl 1):S4-S13. PubMed ID: 33687170
[TBL] [Abstract][Full Text] [Related]
27. Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Matias-Guiu X; Selinger CI; Anderson L; Buza N; Ellenson LH; Fadare O; Ganesan R; Ip PPC; Palacios J; Parra-Herran C; Raspollini MR; Soslow RA; Werner HMJ; Lax SF; McCluggage WG
Int J Gynecol Pathol; 2022 Nov; 41(Suppl 1):S90-S118. PubMed ID: 36305536
[TBL] [Abstract][Full Text] [Related]
28. Endocervical Adenocarcinoma, Gross Examination, and Processing, Including Intraoperative Evaluation: Recommendations From the International Society of Gynecological Pathologists.
Parra-Herran C; Malpica A; Oliva E; Zannoni GF; Ramirez PT; Rabban JT
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S24-S47. PubMed ID: 33570862
[TBL] [Abstract][Full Text] [Related]
29. A Timely Update of Immunohistochemistry and Molecular Classification in the Diagnosis and Risk Assessment of Endometrial Carcinomas.
Wang M; Hui P
Arch Pathol Lab Med; 2021 Nov; 145(11):1367-1378. PubMed ID: 34673912
[TBL] [Abstract][Full Text] [Related]
30. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.
Garg K; Soslow RA
Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of pelvic washing specimens in patients with endometrial cancer: Cytomorphological features, diagnostic agreement, and pathologist experience.
Davis RC; Broadwater G; Foo WC; Jones CK; Havrilesky LJ; Bean SM
Cancer Cytopathol; 2021 Jul; 129(7):517-525. PubMed ID: 33481348
[TBL] [Abstract][Full Text] [Related]
32. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.
Talhouk A; Hoang LN; McConechy MK; Nakonechny Q; Leo J; Cheng A; Leung S; Yang W; Lum A; Köbel M; Lee CH; Soslow RA; Huntsman DG; Gilks CB; McAlpine JN
Gynecol Oncol; 2016 Oct; 143(1):46-53. PubMed ID: 27421752
[TBL] [Abstract][Full Text] [Related]
33. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
Hussein YR; Broaddus R; Weigelt B; Levine DA; Soslow RA
Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
[TBL] [Abstract][Full Text] [Related]
34. Recent developments and selected diagnostic problems in carcinomas of the endometrium.
Ioffe OB
Am J Clin Pathol; 2005 Dec; 124 Suppl():S42-51. PubMed ID: 16468417
[TBL] [Abstract][Full Text] [Related]
35. Inspection for micrometastasis is essential for predicting the prognosis of serous endometrial intraepithelial carcinoma: Case report and literature review.
Yoshioka T; Suzuki Y; Imai Y; Ruiz-Yokota N; Yamanaka S; Furuya M; Miyagi E
J Obstet Gynaecol Res; 2021 Dec; 47(12):4484-4489. PubMed ID: 34494349
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.
Holloway RW; Abu-Rustum NR; Backes FJ; Boggess JF; Gotlieb WH; Jeffrey Lowery W; Rossi EC; Tanner EJ; Wolsky RJ
Gynecol Oncol; 2017 Aug; 146(2):405-415. PubMed ID: 28566221
[TBL] [Abstract][Full Text] [Related]
37. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
[TBL] [Abstract][Full Text] [Related]
38. The diagnosis of mucinous lesions in endometrial samplings by gynaecological pathologists: an analysis of diagnostic reproducibility.
Fadare O; Roma AA; Mhawech-Fauceglia P; Parkash V; Rabban JT
Pathology; 2018 Apr; 50(3):276-285. PubMed ID: 29428179
[TBL] [Abstract][Full Text] [Related]
39. The International Society of Gynecological Pathologists (ISGyP) Endometrial Carcinoma Project.
McCluggage WG; Malpica A; Matias-Guiu X; Oliva E; Parkash V
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S1-S2. PubMed ID: 30550479
[No Abstract] [Full Text] [Related]
40. High-Grade Endometrial Carcinomas: Classification with Molecular Insights.
Carlson JW; Nastic D
Surg Pathol Clin; 2019 Jun; 12(2):343-362. PubMed ID: 31097108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
